Business Context and Reporting Period
This Form 8-K is filed by ReShape Lifesciences Inc. (trading symbol: RSLS) on April 9, 2024. The report addresses a notice from The Nasdaq Stock Market regarding the Company's failure to maintain the minimum $1.00 bid price requirement for continued listing on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance status regarding stock price.
Material Changes and Listing Status
- Initial Notice: On October 10, 2023, the Company received notice of non-compliance with Nasdaq Listing Rule 5550(a)(2) due to a bid price below $1.00.
- Current Status: As of April 9, 2024, the Company has not regained compliance with the minimum bid price requirement.
- Extension Granted: Nasdaq Staff has granted an additional 180-day compliance period, extending until October 7, 2024.
- Compliance Criteria: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days during the extension period.
Outlook, Management Commentary, and Risks
Management intends to actively monitor performance and consider available options to resolve the deficiency. The Company may implement a reverse stock split at a ratio between 1-for-10 and 1-for-60, which was previously approved by stockholders on February 23, 2024. If compliance is not demonstrated by October 6, 2024, the Company faces delisting, at which point it may appeal the determination to a Hearings Panel.
Investor Verification Checklist
- Verify the current trading price of RSLS to assess proximity to the $1.00 threshold.
- Confirm the status of the reverse stock split authorization and any potential implementation timeline.
- Monitor for any future 8-K filings regarding the outcome of the compliance period or delisting proceedings.
- Review the Company's most recent 10-K or 10-Q for underlying financial performance data not included in this 8-K.